R. A. Sacher

Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study

Jennie Orland, John W. Engstrom, Joy Fridey et al. · Neurology · 2003 · 177 citations

A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy

Lawrence T. Goodnough, Thomas H. Price, Kenneth D. Friedman et al. · Transfusion · 1994 · 133 citations

HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors

Edward L. Murphy, Joy Fridey, James W. Smith et al. · Neurology · 1997 · 132 citations

The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double‐blind, controlled trial

Thomas H. Price, Lawrence T. Goodnough, William R. Vogler et al. · Transfusion · 1996 · 95 citations

Neurologic abnormalities in HTLV-I– and HTLV-II–infected individuals without overt myelopathy

Hope H. Biswas, John W. Engstrom, Zhanna Kaidarova et al. · Neurology · 2009 · 67 citations · Full text